These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29760134)

  • 41. Real-time sequencing to decipher the molecular mechanism of resistance of a clinical pan-drug-resistant Acinetobacter baumannii isolate from Marseille, France.
    Rolain JM; Diene SM; Kempf M; Gimenez G; Robert C; Raoult D
    Antimicrob Agents Chemother; 2013 Jan; 57(1):592-6. PubMed ID: 23070160
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular Characterization of Carbapenem-Resistant Acinetobacter baumannii in the Intensive Care Unit of Uruguay's University Hospital Identifies the First rmtC Gene in the Species.
    Bado I; Papa-Ezdra R; Delgado-Blas JF; Gaudio M; Gutiérrez C; Cordeiro NF; García-Fulgueiras V; Araújo Pirez L; Seija V; Medina JC; Rieppi G; Gonzalez-Zorn B; Vignoli R
    Microb Drug Resist; 2018 Sep; 24(7):1012-1019. PubMed ID: 29920143
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular mechanisms associated with nosocomial carbapenem-resistant Acinetobacter baumannii in Mexico.
    Alcántar-Curiel MD; García-Torres LF; González-Chávez MI; Morfín-Otero R; Gayosso-Vázquez C; Jarillo-Quijada MD; Fernández-Vázquez JL; Giono-Cerezo S; Rodríguez-Noriega E; Santos-Preciado JI
    Arch Med Res; 2014 Oct; 45(7):553-60. PubMed ID: 25450581
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Carbapenem-resistant Acinetobacter baumannii ST294 harbouring the OXA-72 carbapenemase from a captive grey parrot.
    Klotz P; Jacobmeyer L; Stamm I; Leidner U; Pfeifer Y; Semmler T; Prenger-Berninghoff E; Ewers C
    J Antimicrob Chemother; 2018 Apr; 73(4):1098-1100. PubMed ID: 29309610
    [No Abstract]   [Full Text] [Related]  

  • 45. Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.
    Jaidane N; Naas T; Mansour W; Radhia BB; Jerbi S; Boujaafar N; Bouallegue O; Bonnin RA
    Int J Antimicrob Agents; 2018 Feb; 51(2):266-269. PubMed ID: 29127051
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan.
    Lee MH; Chen TL; Lee YT; Huang L; Kuo SC; Yu KW; Hsueh PR; Dou HY; Su IJ; Fung CP
    J Microbiol Immunol Infect; 2013 Dec; 46(6):419-24. PubMed ID: 23010539
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.
    Jiang W; Liu H; Zhong M; Yang YC; Xiao DW; Huang WF
    Microb Drug Resist; 2013 Apr; 19(2):117-23. PubMed ID: 22845773
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Acinetobacter baumannii clonal lineages I and II harboring different carbapenem-hydrolyzing-β-lactamase genes are widespread among hospitalized burn patients in Tehran.
    Mahdian S; Sadeghifard N; Pakzad I; Ghanbari F; Soroush S; Azimi L; Rastegar-Lari A; Giannouli M; Taherikalani M
    J Infect Public Health; 2015; 8(6):533-42. PubMed ID: 26111484
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Extensively drug-resistant community-acquired Acinetobacter baumannii sequence type 2 in a dog with urinary tract infection in Thailand.
    Chanchaithong P; Prapasarakul N; Sirisopit Mehl N; Suanpairintr N; Teankum K; Collaud A; Endimiani A; Perreten V
    J Glob Antimicrob Resist; 2018 Jun; 13():33-34. PubMed ID: 29476985
    [No Abstract]   [Full Text] [Related]  

  • 50. Emergence and characterization of nosocomial multidrug-resistant and extensively drug-resistant Acinetobacter baumannii isolates in Tehran, Iran.
    Salehi B; Goudarzi H; Nikmanesh B; Houri H; Alavi-Moghaddam M; Ghalavand Z
    J Infect Chemother; 2018 Jul; 24(7):515-523. PubMed ID: 29555392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High prevalence of OXA-type carbapenemases among Acinetobacter baumannii strains in a teaching hospital of Tehran.
    Zafari M; Feizabadi MM; Jafari S; Abdollahi A; Sabokbar A
    Acta Microbiol Immunol Hung; 2017 Dec; 64(4):385-394. PubMed ID: 28870091
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outbreak Caused by blaOXA-72-Producing Acinetobacter baumannii ST417 Detected in Clinical and Environmental Isolates.
    Tamayo-Legorreta E; Turrubiartes-Martínez E; Garza-Ramos U; Niño-Moreno P; Barrios H; Sánchez-Pérez A; Reyna-Flores F; Tovar-Oviedo J; Magaña-Aquino M; Cevallos MA; Silva-Sanchez J
    Microb Drug Resist; 2016 Mar; 22(2):129-33. PubMed ID: 26954369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nursing Home as a Reservoir of Carbapenem-Resistant Acinetobacter baumannii.
    Bedenić B; Beader N; Godič-Torkar K; Vranić-Ladavac M; Luxner J; Veir Z; Grisold AJ; Zarfel G
    Microb Drug Resist; 2015 Jun; 21(3):270-8. PubMed ID: 25599131
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
    Lesho E; Yoon EJ; McGann P; Snesrud E; Kwak Y; Milillo M; Onmus-Leone F; Preston L; St Clair K; Nikolich M; Viscount H; Wortmann G; Zapor M; Grillot-Courvalin C; Courvalin P; Clifford R; Waterman PE
    J Infect Dis; 2013 Oct; 208(7):1142-51. PubMed ID: 23812239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prevalence of antibiotic resistance among Acinetobacter baumannii isolates from Aleppo, Syria.
    Hamzeh AR; Al Najjar M; Mahfoud M
    Am J Infect Control; 2012 Oct; 40(8):776-7. PubMed ID: 22305413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Elevated prevalence of multidrug-resistant Acinetobacter baumannii with extensive genetic diversity in the largest burn centre of northeast Iran.
    Sarhaddi N; Soleimanpour S; Farsiani H; Mosavat A; Dolatabadi S; Salimizand H; Amel Jamehdar S
    J Glob Antimicrob Resist; 2017 Mar; 8():60-66. PubMed ID: 28011349
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial Resistance Mechanisms and Genetic Diversity of Multidrug-Resistant Acinetobacter baumannii Isolated from a Teaching Hospital in Malaysia.
    Biglari S; Hanafiah A; Mohd Puzi S; Ramli R; Rahman M; Lopes BS
    Microb Drug Resist; 2017 Jul; 23(5):545-555. PubMed ID: 27854165
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Emergence of multidrug-resistant Acinetobacter baumannii producing OXA-23 carbapenemase, Nigeria.
    Olaitan AO; Berrazeg M; Fagade OE; Adelowo OO; Alli JA; Rolain JM
    Int J Infect Dis; 2013 Jun; 17(6):e469-70. PubMed ID: 23337460
    [No Abstract]   [Full Text] [Related]  

  • 59. Investigation of the clonal associations in
    Ozyurt S; Kostakoglu U; Yildiz IE; Erturk A; Sonmez E; Sahin U; Cicek AC
    Niger J Clin Pract; 2020 Aug; 23(8):1155-1162. PubMed ID: 32788495
    [TBL] [Abstract][Full Text] [Related]  

  • 60. GES-11-producing Acinetobacter baumannii clinical isolates from Tunisian hospitals: Long-term dissemination of GES-type carbapenemases in North Africa.
    Chihi H; Bonnin RA; Bourouis A; Mahrouki S; Besbes S; Moussa MB; Belhadj O; Naas T
    J Glob Antimicrob Resist; 2016 Jun; 5():47-50. PubMed ID: 27436466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.